Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317054,Aia12,Adjuvant induced arthritis QTL 12,4.24,,joint integrity trait (VT:0010548),left rear ankle joint diameter (CMO:0002149),17,38281509,83281509,Rat,n/a,region,qtl 1000,2317035,Aia16,Adjuvant induced arthritis QTL 16,2.71,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),7,59238038,104238038,Rat,n/a,region,qtl 1000,2317052,Aia17,Adjuvant induced arthritis QTL 17,2.13,,joint integrity trait (VT:0010548),left rear ankle joint diameter (CMO:0002149),7,81737938,126737938,Rat,n/a,region,qtl 1000,2317053,Aia25,Adjuvant induced arthritis QTL 25,2.69,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),17,50909196,60781426,Rat,n/a,region,qtl 1000,2317060,Aia26,Adjuvant induced arthritis QTL 26,3.22,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),17,38281509,83281509,Rat,n/a,region,qtl 1000,12903981,Am17,Aortic mass QTL 17,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),17,23653184,68653184,Rat,n/a,region,qtl 1000,634336,Anxrr17,Anxiety related response QTL 17,3.66,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),7,924703,115097879,Rat,n/a,region,qtl 1000,1358295,Aocep1,Aortic cell protein QTL 1,6.1,0.00000071,thoracic aorta cellular protein amount (VT:0010598),aortic cell percentage,17,40990005,85990005,Rat,n/a,region,qtl 1000,2313102,Bmd79,Bone mineral density QTL 79,2.3,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),7,94811085,116738842,Rat,n/a,region,qtl 1000,1298528,Bp169,Blood pressure QTL 169,,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),7,61074194,106074194,Rat,n/a,region,qtl 1000,1300151,Bp181,Blood pressure QTL 181,3.36,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),7,53612714,103945643,Rat,n/a,region,qtl 1000,1300148,Bp192,Blood pressure QTL 192,3.47,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),17,34550843,73951021,Rat,n/a,region,qtl 1000,1331728,Bp214,Blood pressure QTL 214,2.825,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),7,80221299,124373579,Rat,n/a,region,qtl 1000,1354619,Bp242,Blood pressure QTL 242,6.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),17,24599340,69599340,Rat,n/a,region,qtl 1000,1354635,Bp245,Blood pressure QTL 245,6,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),17,42073160,69599340,Rat,n/a,region,qtl 1000,1354635,Bp245,Blood pressure QTL 245,6,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),17,42073160,69599340,Rat,n/a,region,qtl 1000,1354581,Bp247,Blood pressure QTL 247,4.5,,arterial blood pressure trait (VT:2000000),pulse pressure (CMO:0000292),17,1,69599340,Rat,n/a,region,qtl 1000,1358891,Bp265,Blood pressure QTL 265,2.21,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),7,83591953,134666232,Rat,n/a,region,qtl 1000,1358914,Bp266,Blood pressure QTL 266,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),7,83591953,134666232,Rat,n/a,region,qtl 1000,1559055,Bp278,Blood pressure QTL 278,,0.04,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),17,23653184,68653184,Rat,n/a,region,qtl 1000,61357,Bp38,Blood pressure QTL 38,1.6,0.052,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),7,41333674,119109060,Rat,n/a,region,qtl 1000,10450503,Bp386,Blood pressure QTL 386,,0.28,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),17,31368391,62109574,Rat,n/a,region,qtl 1000,61394,Bp8,Blood pressure QTL 8,2.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),17,23080567,59555013,Rat,n/a,region,qtl 1000,631497,Bp98,Blood pressure QTL 98,3.66,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),17,41354651,60463643,Rat,n/a,region,qtl 1000,4889955,Bss93,Bone structure and strength QTL 93,4.4,,tibia size trait (VT:0100001),tibia cortical bone volume to tibia total bone volume ratio (CMO:0001727),17,27027949,60463643,Rat,n/a,region,qtl 1000,1354588,Bvd4,Brain ventricular dilatation QTL 4,5.31,0.001,brain ventricle morphology trait (VT:0000822),hydrocephalus severity score (CMO:0001881),17,53498828,82479847,Rat,n/a,region,qtl 1000,1354663,Bvd5,Brain ventricular dilatation QTL 5,3.51,0.001,brain ventricle morphology trait (VT:0000822),hydrocephalus severity score (CMO:0001881),17,31990784,81292925,Rat,n/a,region,qtl 1000,634322,Bw12,Body weight QTL 12,0,,body mass (VT:0001259),body weight (CMO:0000012),7,83153392,128153392,Rat,n/a,region,qtl 1000,7411575,Bw140,Body weight QTL 140,30.2,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),17,48560935,86533673,Rat,n/a,region,qtl 1000,8694181,Bw151,Body weight QTL 151,4.36,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),17,48560935,86533673,Rat,n/a,region,qtl 1000,61397,Bw17,Body weight QTL 17,6.3,,body mass (VT:0001259),body weight (CMO:0000012),7,93595647,106839474,Rat,n/a,region,qtl 1000,1354596,Bw32,Body weight QTL 32,4.5,,body mass (VT:0001259),body weight (CMO:0000012),17,4299130,60781592,Rat,n/a,region,qtl 1000,631540,Bw9,Body weight QTL 9,4.5,,body mass (VT:0001259),body weight (CMO:0000012),7,69736226,117455174,Rat,n/a,region,qtl 1000,12903978,Cm118,Cardiac mass QTL 118,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),17,23653184,68653184,Rat,n/a,region,qtl 1000,12903979,Cm119,Cardiac mass QTL 119,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),17,23653184,68653184,Rat,n/a,region,qtl 1000,12903980,Cm120,Cardiac mass QTL 120,,0.002,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),17,23653184,68653184,Rat,n/a,region,qtl 1000,70210,Cm15,Cardiac mass QTL 15,6.5,,heart right ventricle mass (VT:0007033),heart right ventricle wet weight (CMO:0000072),17,57246723,70156904,Rat,n/a,region,qtl 1000,631504,Cm27,Cardiac mass QTL 27,3.45,,heart left ventricle mass (VT:0007031),heart left ventricle wet weight (CMO:0000071),7,44421311,118198041,Rat,n/a,region,qtl 1000,1354630,Cm34,Cardiac mass QTL 34,8.7,,heart left ventricle mass (VT:0007031),heart left ventricle wet weight (CMO:0000071),17,4299130,69599340,Rat,n/a,region,qtl 1000,1300149,Cm6,Cardiac mass QTL 6,4.09,,heart mass (VT:0007028),heart left ventricle weight to body weight ratio (CMO:0000530),7,43747099,102228765,Rat,n/a,region,qtl 1000,2324621,Coatc5,Coat color QTL 5,,,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),17,31368391,73951021,Rat,n/a,region,qtl 1000,4889894,Eae33,Experimental allergic encephalomyelitis QTL 33,5.2,0.0001,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),17,50909099,86022412,Rat,n/a,region,qtl 1000,2298475,Eau6,Experimental allergic uveoretinitis QTL 6,,0.0029,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),7,84257275,129257275,Rat,n/a,region,qtl 1000,1600398,Edcs5,Endometrial carcinoma susceptibility QTL 5,2.2,,uterus morphology trait (VT:0001120),percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759),17,57246723,70852846,Rat,n/a,region,qtl 1000,1559283,Emca4,Estrogen-induced mammary cancer QTL 4,3.7,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),7,62004452,101773158,Rat,n/a,region,qtl 1000,1576303,Ept7,Estrogen-induced pituitary tumorigenesis QTL 7,3.7,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),7,62004452,101773158,Rat,n/a,region,qtl 1000,7411607,Foco15,Food consumption QTL 15,,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),7,75918751,120918751,Rat,n/a,region,qtl 1000,7411654,Foco25,Food consumption QTL 25,9.3,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),7,75918751,120918751,Rat,n/a,region,qtl 1000,2317038,Ginf3,Gastrointestinal inflammation QTL 3,2.89,0.005,liver integrity trait (VT:0010547),liver granuloma severity score (CMO:0002157),17,49920154,86533673,Rat,n/a,region,qtl 1000,731176,Glom5,Glomerulus QTL 5,2.5,0.0035,kidney glomerulus morphology trait (VT:0005325),count of superficial glomeruli not directly contacting the kidney surface (CMO:0001002),7,96670164,135012528,Rat,n/a,region,qtl 1000,2302365,Gluco40,Glucose level QTL 40,4.79,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),17,57246843,82046127,Rat,n/a,region,qtl 1000,2303580,Gluco49,Glucose level QTL 49,2,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),17,50040271,86533673,Rat,n/a,region,qtl 1000,1357336,Gluco6,Glucose level QTL 6,3.4,,blood glucose amount (VT:0000188),serum glucose level (CMO:0000543),7,94811326,116294265,Rat,n/a,region,qtl 1000,631687,Hcas1,Hepatocarcinoma susceptibility QTL 1,3.9,0.001,liver integrity trait (VT:0010547),liver tumorous lesion volume to total liver volume ratio (CMO:0001082),7,91412594,129807172,Rat,n/a,region,qtl 1000,2299163,Iddm34,Insulin dependent diabetes mellitus QTL 34,2.71,,blood glucose amount (VT:0000188),age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140),7,91281130,135012528,Rat,n/a,region,qtl 1000,1354638,Insul1,Insulin level QTL 1,4.8,,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),17,4299130,69599340,Rat,n/a,region,qtl 1000,1331768,Kidm10,Kidney mass QTL 10,4.62096,,kidney mass (VT:0002707),left kidney wet weight (CMO:0000083),7,80221299,125221299,Rat,n/a,region,qtl 1000,2301412,Kidm40,Kidney mass QTL 40,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),17,37479847,82479847,Rat,n/a,region,qtl 1000,1300179,Kidm5,Kidney mass QTL 5,3.51,,kidney mass (VT:0002707),left kidney wet weight (CMO:0000083),7,43747012,135012528,Rat,n/a,region,qtl 1000,12903982,Kidm70,Kidney mass QTL 70,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),17,23653184,70974005,Rat,n/a,region,qtl 1000,1331746,Kidm9,Kidney mass QTL 9,3.934,,kidney mass (VT:0002707),right kidney wet weight (CMO:0000082),7,80221299,112308525,Rat,n/a,region,qtl 1000,1354651,Lmblg2,Limb length QTL 2,6,,tibia length (VT:0004357),tibia length (CMO:0000450),17,4299130,69599340,Rat,n/a,region,qtl 1000,7394837,Memor18,Memory QTL 18,,,exploratory behavior trait (VT:0010471),"measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)",17,18640182,63640182,Rat,n/a,region,qtl 1000,1598871,Memor5,Memory QTL 5,5.3,,exploratory behavior trait (VT:0010471),total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443),17,40540041,80387013,Rat,n/a,region,qtl 1000,61466,Niddm12,Non-insulin dependent diabetes mellitus QTL 12,3.2,0.001,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),17,54029929,60463637,Rat,n/a,region,qtl 1000,71114,Niddm14,Non-insulin dependent diabetes mellitus QTL 14,4.5,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),7,84257275,129257275,Rat,n/a,region,qtl 1000,70173,Niddm19,Non-insulin dependent diabetes mellitus QTL 19,4.33,0.00005,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),7,64002457,135012528,Rat,n/a,region,qtl 1000,724549,Niddm56,Non-insulin dependent diabetes mellitus QTL 56,,0.03,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),17,31990784,76990784,Rat,n/a,region,qtl 1000,1643004,Pain2,Pain QTL 2,1,,mechanical nociception trait (VT:0002734),self mutilation severity score (CMO:0002145),7,9462246,98011544,Rat,n/a,region,qtl 1000,634331,Pia17,Pristane induced arthritis QTL 17,4.7,,joint integrity trait (VT:0010548),arthritic paw count (CMO:0001460),7,73829340,130221005,Rat,n/a,region,qtl 1000,8552928,Pigfal9,Plasma insulin-like growth factor 1 level QTL 9,9,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),17,28409147,73409147,Rat,n/a,region,qtl 1000,2316952,Pur22,Proteinuria QTL 22,5.2,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),7,68938720,113886318,Rat,n/a,region,qtl 1000,1354662,Rf49,Renal function QTL 49,2.9,,blood creatinine amount (VT:0005328),plasma creatinine level (CMO:0000537),17,1,69599340,Rat,n/a,region,qtl 1000,2316947,Rf58,Renal function QTL 58,7.8,,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),7,68938720,113886318,Rat,n/a,region,qtl 1000,1354629,Scl31,Serum cholesterol level QTL 31,4.1,,blood cholesterol amount (VT:0000180),blood total cholesterol level (CMO:0000051),17,50890908,60781592,Rat,n/a,region,qtl 1000,1354640,Scl32,Serum cholesterol level QTL 32,5.4,,blood HDL cholesterol amount (VT:0000184),blood high density lipoprotein cholesterol level (CMO:0000052),17,15781592,60781592,Rat,n/a,region,qtl 1000,1354659,Scl68,Serum cholesterol level QTL 68,3.9,,blood VLDL cholesterol amount (VT:0005144),blood very low density lipoprotein cholesterol level (CMO:0000648),17,15781592,60781592,Rat,n/a,region,qtl 1000,10450828,Scl79,Serum cholesterol level QTL 79,3.5,0.001,blood HDL cholesterol amount (VT:0000184),blood low density lipoprotein cholesterol level (CMO:0000053),7,89867376,101773158,Rat,n/a,region,qtl 1000,9590107,Sffal7,Serum free fatty acids level QTL 7,4.81,0.001,blood free fatty acid amount (VT:0001553),plasma free fatty acids level (CMO:0000546),17,28409147,73409147,Rat,n/a,region,qtl 1000,1354654,Spl7,Serum phospholipid level QTL 7,5.5,,blood phospholipid amount (VT:0006084),blood phospholipid level (CMO:0001169),17,50890908,60781592,Rat,n/a,region,qtl 1000,1354658,Spl8,Serum phospholipid level QTL 8,3.8,,blood VLDL phospholipid amount (VT:0010507),blood very low density lipoprotein phospholipid level (CMO:0001571),17,1,60781592,Rat,n/a,region,qtl 1000,1358361,Sradr5,Stress Responsive Adrenal Weight QTL 5,5.55,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),7,43747012,108555253,Rat,n/a,region,qtl 1000,1354628,Stl13,Serum triglyceride level QTL 13,3.8,,blood triglyceride amount (VT:0002644),blood triglyceride level (CMO:0000118),17,21293039,60781592,Rat,n/a,region,qtl 1000,1357338,Stl17,Serum triglyceride level QTL 17,3.23,,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),7,69736356,112729554,Rat,n/a,region,qtl 1000,2316955,Stl24,Serum triglyceride level QTL 24,7.1,,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),7,68938720,113886318,Rat,n/a,region,qtl 1000,1549899,Stresp8,Stress response QTL 8,4.37,0.0008,stress-related behavior trait (VT:0010451),defensive burying duration (CMO:0001961),7,90482196,135012528,Rat,n/a,region,qtl 1000,1558655,Swd4,Spike wave discharge measurement QTL 4,3.68,0.0002,brain electrophysiology trait (VT:0010557),brain spike-and-wave discharge severity grade (CMO:0001988),7,86983365,131983365,Rat,n/a,region,qtl 1000,631529,Tls2,T-lymphoma susceptibility QTL 2,0,0.001,thymus integrity trait (VT:0010555),percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911),7,80221299,109401111,Rat,n/a,region,qtl 1000,724528,Uae4,Urinary albumin excretion QTL 4,4.9,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),17,35837085,69599340,Rat,n/a,region,qtl